EXANE DERIVATIVES

Q4 2016 13F Holdings Report, Stock Holdings

Signature - Title
Corinne Fleck - head of Regulatory affairs and reportings.
Location
Paris, France
Holdings as of
December 31, 2016
Value $
$425M
Num holdings
587
Date filed
1/27/2017, 11:23 AM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q3 2016 - Oct 26, 2016
Next filing
Q1 2017 - Apr 28, 2017
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2016 Q4 compared to 2016 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Corinne Fleck Head of Regulatory affairs and reporting Paris, France 1/27/2017